Hot topic—News ｜ Bio@Taipei

News

Navigating Medtech Tariffs: Insights on Supply Chain Resilience, Cost Management, and Strategic Adaptation

2025.11.28

J&J MedTech bolsters stroke R&D programs in Ireland

2025.11.25

Japan’s Biotech Is Repositioning for Scale: JBA’s Tsukamoto on Capital, Capacity, and Cross-Border Models

2025.11.20

The Tiny Power Revolution Behind Consumer CGMs

2025.11.18

Celebrate a Century of VA Innovation by Collaborating on Your Next Medical Product

2025.11.13

Prosthetics: Firms Like Unhindr And Esper Shape Market On the Cusp of Great Change

2025.11.11

South Korea’s Celltrion Inks $744 Million Deal with U.S. Biotech, Eyeing Autoimmune Drug Market

2025.11.06

UK MHRA Deepens AI Regulatory Expertise As Airlock Moves Into Phase 2

2025.11.04

First FDA IND Milestone Achieved Using Human Vascularized Organoid Efficacy Data

2025.10.30

Next-Gen Cancer Care: Bispecifics, Smart Dosing, and System-Level Thinking at ESMO 2025

2025.10.28

Precision Oncology in Focus at ESMO 2025: New Data Across Rare Cancers, CML, and Solid Tumors

2025.10.23

Teaching the Immune System When to Say “Yes” or “No”: Nobel Laureate Dr. Shimon Sakaguchi’s Treg Discovery in Cancer, Autoimmunity, and Drug Development

2025.10.21

From Lab Bench to Global Market: A Practical Playbook for Japan’s Biotech Startups

2025.10.16

MapLight illuminates $262M IPO plans to fund Cobenfy competitor

2025.10.14

4 medtech topics to watch for the rest of 2025

2025.10.09

Total 19

Total 19

Back to top